During the past decade, Asl Salerno, Presidio Ospedaliero Tortora Pagani - Ematologia conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 1 clinical trials were completed, i.e. on average, 6.7% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Asl Salerno, Presidio Ospedaliero Tortora Pagani - Ematologia" #1 collaborator was "Fondazione Italiana Linfomi ONLUS" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Asl Salerno, Presidio Ospedaliero Tortora Pagani - Ematologia" are "Acute Myeloid Leukemia" (4 trials), "Acute Lymphoblastic Leukemia" (2 trials), "Chronic Lymphocytic Leukemia" (2 trials), "ALL, Adult" (1 trials) and "Acute Lymphoblastic Leukemia (Philadelphia Chromosome Positive)" (1 trials). Many other conditions were trialed in "Asl Salerno, Presidio Ospedaliero Tortora Pagani - Ematologia" in a lesser frequency.

Most popular intervention types in "Asl Salerno, Presidio Ospedaliero Tortora Pagani - Ematologia" are "Drug" (14 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Rituximab" (4 trials), "Ibrutinib" (2 trials), "Imatinib" (2 trials), "Obinutuzumab" (2 trials) and "Venetoclax" (2 trials). Other intervention names were less common.

The vast majority of trials in "Asl Salerno, Presidio Ospedaliero Tortora Pagani - Ematologia" are 17 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Asl Salerno, Presidio Ospedaliero Tortora Pagani - Ematologia". undefined are not yet recruiting, 6 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Asl Salerno, Presidio Ospedaliero Tortora Pagani - Ematologia, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Asl Salerno, Presidio Ospedaliero Tortora Pagani - Ematologia, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".

Asl Salerno, Presidio Ospedaliero Tortora Pagani - Ematologia has several departments that took part in Clinical trials: "Presidio Osped. S. Maria Della Speranza, U.O. Di Cardiologia" - 5 trials, "Inferiore U.O. Medicina Interna Ematologia ed Oncologia P.O. Umberto I" - 3 trials